Beaconcure
Latest round
- Series B
Last raised
- Feb 2023
Total raised
- $9.9M
Investors
- 1
About Beaconcure
Based in Tel Aviv, Israel, and founded in 2016, Beaconcure operates as a business support service provider which offers artificial intelligence technology-based services to biopharmaceutical companies for drug development and regulatory approvals. The company was Co-founded by Yoran Bar (CEO) and Ilan Carmeli (COO). As of 2022, the firm is having 2 offices in Israel and US. The company offers Biopharmaceutical companies and CROs automated clinical trial data processing solutions. It offers a cloud-based, Artificial Intelligence-driven clinical data analytics platform, designed with Pfizer to accelerate the introduction of new drugs and vaccines to the market for the benefit of patients worldwide. The platform helps clients to convert static data into a machine-readable format and automate manual checks. It helps in tracking and reporting study progress and audit trial.
Who invested in Beaconcure
1 investor across 1 round
See all investors in Beaconcure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 27, 2023
Amount
$9.9M
Investors
Questions about Beaconcure
Who invested in Beaconcure?
Beaconcure has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beaconcure raised?
Beaconcure has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beaconcure last raise money?
Beaconcure's most recent round on record is a Series B, in Feb 2023.
What does Beaconcure do?
Based in Tel Aviv, Israel, and founded in 2016, Beaconcure operates as a business support service provider which offers artificial intelligence technology-based services to biopharmaceutical companies for drug development and regulatory approvals.
Where is Beaconcure headquartered?
Beaconcure is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like Beaconcure?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Beaconcure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Beaconcure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.